Two years after U2 disappointment, TG Therapeutics wins back investors with PFS win — setting the stage for NDA
September 2018 was supposed to hold a crucial moment for TG Therapeutics. It was the month that researchers were due to analyze the overall response …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.